velpatasvir
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
A novel and sensitive LC-MS/MS method was developed, optimized and validated for quantification of sofosbuvir (SOF) and…
The optimal retreatment strategy for patients chronically infected with hepatitis C virus who experience virologic failure after…
The burden of HCV cirrhosis is high and projected to increase significantly over the next decade. While interferon therapy is…
In this analysis of the ASTRAL trials (non-opioid substitution therapy [OST], n = 984; OST, n = 51) evaluating the once-daily…
Background and ObjectivesVelpatasvir (VEL; GS-5816) is a potent, pangenotypic hepatitis C virus (HCV), non-structural protein 5A…
BACKGROUND
As the population that is infected with the hepatitis C virus (HCV) ages, the number of patients with decompensated…
Context Options are needed when initial therapy fails for hepatitis C virus (HCV) infection. Contribution In a phase 2 trial…